- Cancer Information
- LGBTQI+ People and Cancer
- Intersex people and cancer
- Challenges you might face
Challenges you might face as an intersex person
Intersex people diagnosed with cancer may face several challenges.
Learn more about:
- Having had prior surgery without your consent
- Feelings of distrust
- Increased cancer risk
- Cancer screening
- Taking hormones
- Terms used
- Ongoing side effects
- Gendered treatment
- Body image
Having had prior surgery without your consent
Many intersex people had surgery as a child to assign a sex, to make their body align with gendered norms for male and female bodies, or to reduce the risk of cancer. This surgery may have changed the appearance or removed parts of the genitals and reproductive organs. It may have been done before you had the chance to decide, or your parents may not have received enough information about the impact of the surgery to be able to give informed consent. Some people reject the assigned sex when they are old enough to decide their gender, and sometimes the surgery may not have been medically necessary. Both of these things can add to feelings of distress about having had prior surgery.
Feelings of distrust
You may have lost trust in family and health professionals who made decisions for you during childhood without your consent, particularly if you didn’t find out about previous surgeries or medical interventions until you were an adult. Being told that doctors need to “fix” your body can make you feel ashamed and stigmatised. Some intersex people distrust the medical profession because of being made to feel like a research subject for doctors to learn from, being photographed or being asked insensitive questions about their genitals and internal organs.
Increased cancer risk
Some syndromes that cause intersex variations increase the risk of cancer. For example, males with 47,XXY (Klinefelter syndrome) have an increased risk of developing non-Hodgkin lymphoma and breast cancer.
The risk of gonadal cancer (cancer in the tissue that becomes testicles and ovaries) is also higher in people with some intersex variations such as 46,XY complete gonadal dysgenesis (Swyer syndrome). Surgery to remove the gonads may reduce cancer risk, however, this surgery has often been done on people with very low cancer risk. For some, ongoing monitoring can be a better way of managing this cancer risk. Talk to your doctors about the cancer risk for your variation.
Talk to your doctors about suitable screening tests for you. Depending on your variation, the sex assigned at birth or any medical interventions you’ve had, you may not receive appropriate screening reminders for breast or cervical cancer, or you may receive notifications that you don’t need. If you find the idea of screening tests difficult, talk to your GP or nurse. Ask them to explain what will happen. For some screening tests you may be able to collect the sample yourself, either at home (bowel cancer screening) or at the doctor’s office (cervical cancer screening).
You may have been prescribed hormones to supply the body with the sex hormones that it is not able to produce naturally or to bring on sexual development at puberty. If you’ve had surgery to remove the gonads, you may need lifelong hormone replacement therapy. This can be confronting if you did not give your consent for the surgery. You may also be on hormone therapy to affirm your gender if the sex assigned at birth does not match your gender as an adult.
Some cancers grow in response to hormones. Depending on the type of cancer and treatment you have, you may not be able to keep taking hormones prescribed for your intersex variation. It is important to discuss this with your cancer specialists, so you can make informed decisions about your future treatment.
Health professionals can use a wide range of terms to describe intersex variations, including differences or disorders of sex development. You may find some terms offensive or distressing. Let your cancer care team know the terms you would like them to use.
Ongoing side effects
Previous surgery may have led to scarring, infertility, incontinence or loss of sexual function, which can all cause anxiety and mental distress. You may have had further surgeries as an adult to deal with some of these issues.
Some cancers are diagnosed and treated in a gendered way. This may make you feel excluded or stigmatised for not matching other people’s ideas of what it is to be a man or woman. Outdated forms may not include options to record intersex variations. Being made to feel different can lead to distress when you are talking with health professionals about cancer.
Surgery to treat cancer may remove a body part. You may be accepting of the change or you may be upset because you have lost a part that is important to your sense of self. You can talk about how you’re feeling with your treatment team before surgery. If you have previously had parts of your body removed without your consent, having to lose another body part may trigger feelings of distress. For more information, see the Body image, gender and cancer.
Some intersex people are fertile and others are not. It depends on the type of intersex variation as well as any surgery they may have had during childhood to remove testicles or ovaries. Given that many decisions that can affect future fertility are made before adulthood, and often without the consent of the person, it’s natural to feel grief and loss.
Some cancer treatments can also cause issues with fertility. People whose fertility is also affected by their intersex variation, say the emotions can be especially strong. It’s best to talk to a fertility specialist before treatment starts for information specific to you.
Podcast for people affected by cancer
The information on this page is also available for download.
We thank the chief investigators from the Out with Cancer research project: Prof Jane Ussher, Prof Janette Perz, Prof Martha Hickey, Prof Suzanne Chambers, Prof Gary Dowsett, Prof Ian Davis, Prof Katherine Boydell, Prof Kerry Robinson and Dr Chloe Parton. Partner investigators were Dr Fiona McDonald and A/Prof Antoinette Anazodo. Research Associates were Dr Rosalie Power, Dr Kimberley Allison and Dr Alexandra J. Hawkey.
We thank the reviewers of our LGBTQI+ People and Cancer booklet: Prof Jane Ussher, Chair, Women’s Heath Psychology and Chief Investigator, Out with Cancer study, Western Sydney University, NSW; ACON; Dr Kimberley Allison, Out with Cancer study, Western Sydney University, NSW; Dr Katherine Allsopp, Supportive and Palliative Care Specialist, Westmead Hospital, NSW; A/Prof Antoinette Anazodo OAM, Paediatric and Adolescent Oncologist, Sydney Children’s Hospital, NSW; Megan Bathgate, Consumer; Gregory Bock, Clinical Nurse Consultant–Oncology Coordinator, Urology Cancer Nurse Coordination Service, WA Cancer & Palliative Care Network, WA; Morgan Carpenter, Executive Director, Intersex Human Rights Australia (formerly OII Australia); Prof Lorraine Chantrill, Medical Co-Director Cancer Services, Illawarra Shoalhaven Local Health District, NSW; A/Prof Ada Cheung, Endocrinologist, Head, Trans Health Research Group, Department of Medicine (Austin Health), The University of Melbourne, VIC; Bonney Corbin, Australian Women’s Health Network; Cristyn Davies, Research Fellow, Specialty of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney and Children’s Hospital Westmead Clinical School, NSW; Prof Ian Davis, Professor of Medicine, Monash University and Eastern Health, Medical Oncologist, Eastern Health, Chair, ANZUP Cancer Trials Group, VIC; Rebecca Dominguez, President, Bisexual Alliance Victoria; Liz Duck-Chong, Projects Coordinator, TransHub and Trans Health Equity, ACON, NSW; Lauren Giordano, 13 11 20 Consultant, Cancer Council NSW; Hall & Wilcox (law firm); Natalie Halse, BCNA Consumer Representative; Jem Hensley, Consumer; Prof Martha Hickey, Professor of Obstetrics and Gynaecology, The University of Melbourne, and Director of the Gynaecology Research Centre, The Women’s Hospital, VIC; Kim Hobbs, Clinical Specialist Social Worker – Gynaecological Cancer, Westmead Hospital, NSW; Dr Laura Kirsten, Principal Clinical Psychologist, Nepean Cancer Care Centre, NSW; Amber Loomis, Policy and Research Coordinator, LGBTIQ+ Health Australia; Julie McCrossin and Melissa Gibson, Consumers; Dr Fiona McDonald, Research Manager, Canteen, NSW; Dr Gary Morrison, Shine a Light (LGBTQIA+ Cancer Support Group); Penelope Murphy, Cancer Council NSW Liaison, Prince of Wales Hospital, NSW; Dr Rosalie Power, Out with Cancer study, Western Sydney University, NSW; Jan Priaulx, 13 11 20 Consultant, Cancer Council NSW; Paul Scott-Williams, Consumer; Simone Sheridan, Sexual Health Nurse Consultant, Sexual Health Services, Austin Health, VIC; Cheryl Waller and Rhonda Beach, Consumers.
View the Cancer Council NSW editorial policy.